Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.

Kikuchi, Jiro; Yamada, Satoshi; Koyama, Daisuke; Wada, Taeko; Nobuyoshi, Masaharu; Izumi, Tohru; Akutsu, Miyuki; Kano, Yasuhiko; Furukawa, Yusuke.

J Biol Chem ; 288(35): 25593-25602, 2013 Aug 30.

Artículo en Inglés | MEDLINE | ID: mdl-23878197

2.

ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412.

Chi, Hoang Thanh; Ly, Bui Thi Kim; Kano, Yasuhiko; Tojo, Arinobu; Watanabe, Toshiki; Sato, Yuko.

Biochem Biophys Res Commun ; 429(1-2): 87-92, 2012 Dec 07.

Artículo en Inglés | MEDLINE | ID: mdl-23131561

3.

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.

Kikuchi, Jiro; Wada, Taeko; Shimizu, Rumi; Izumi, Tohru; Akutsu, Miyuki; Mitsunaga, Kanae; Noborio-Hatano, Kaoru; Nobuyoshi, Masaharu; Ozawa, Keiya; Kano, Yasuhiko; Furukawa, Yusuke.

Blood ; 116(3): 406-17, 2010 Jul 22.

Artículo en Inglés | MEDLINE | ID: mdl-20351311

4.

[Clinical analysis of 3 cases with primary splenic diffuse large B-cell lymphoma].

Tanaka, Masaru; Tsunoda, Saburo; Inoue, Koichi; Izumi, Tooru; Yamamoto, Takanobu; Hoshi, Sayuri; Hirabayashi, Kaoru; Igarashi, Seiji; Akutsu, Miyuki; Kano, Yasuhiko.

Rinsho Ketsueki ; 52(8): 703-7, 2011 Aug.

Artículo en Japonés | MEDLINE | ID: mdl-21897078

5.

The juxtamembrane domain in ETV6/FLT3 is critical for PIM-1 up-regulation and cell proliferation.

Vu, Hoang Anh; Xinh, Phan Thi; Kano, Yasuhiko; Tokunaga, Katsushi; Sato, Yuko.

Biochem Biophys Res Commun ; 383(3): 308-13, 2009 Jun 05.

Artículo en Inglés | MEDLINE | ID: mdl-19345670

6.

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.

Hatsumi, Nahoko; Miyawaki, Shuichi; Yamauchi, Takahiro; Takeshita, Akihiro; Komatsu, Norio; Usui, Noriko; Arai, Yukihiro; Ishida, Fumihiro; Morii, Takeshi; Kano, Yasuhiko; Ogura, Michinori; Machida, Shinichiro; Nishii, Kazuhiro; Honda, Sumihisa; Ohnishi, Kazunori; Naoe, Tomoki.

Int J Hematol ; 109(4): 418-425, 2019 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-30725360

7.

Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.

Nakajima, Takako Eguchi; Yasunaga, Masahiro; Kano, Yasuhiko; Koizumi, Fumiaki; Kato, Ken; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shirao, Kuniaki; Shimada, Yasuhiro; Matsumura, Yasuhiro.

Int J Cancer ; 122(9): 2148-53, 2008 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-18196580

8.

Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute.

Akutsu, Miyuki; Tsunoda, Saburo; Izumi, Tohru; Tanaka, Masaru; Katano, Susumu; Inoue, Koichi; Igarashi, Seiji; Hirabayashi, Kaoru; Furukawa, Yusuke; Ohmine, Ken; Sato, Kazuya; Kobayashi, Hiroyuki; Ozawa, Keiya; Kirito, Keita; Nagashima, Takahiro; Teramukai, Satoshi; Fukushima, Masanori; Kano, Yasuhiko.

Oncol Res ; 17(3): 137-49, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-18669165

9.

Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).

Miyawaki, Shuichi; Kawai, Yasukazu; Takeshita, Akihiro; Komatsu, Norio; Usui, Noriko; Arai, Yukihiro; Ishida, Fumihiro; Morii, Takeshi; Kano, Yasuhiko; Ogura, Michinori; Doki, Noriko; Ohno, Ryuzo.

Int J Hematol ; 86(4): 343-7, 2007 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-18055342

10.

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy.

Mori, Kiyoshi; Kamiyama, Yukari; Kondo, Tetsuro; Kano, Yasuhiko; Kodama, Tetsuro.

Cancer Chemother Pharmacol ; 60(2): 189-95, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17096163

11.

[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].

Tsunoda, Saburo; Kobayashi, Hiroyuki; Inoue, Koichi; Izumi, Tohru; Akutsu, Miyuki; Katano, Susumu; Ueda, Tomoki; Shirai, Toshitaka; Masuda, Yoshihiro; Ohmine, Kenichi; Nagashima, Takahiro; Ueda, Masuzu; Takagi, Syojiro; Muroi, Kazuo; Ozawa, Keiya; Kano, Yasuhiko.

Gan To Kagaku Ryoho ; 34(6): 885-9, 2007 Jun.

Artículo en Japonés | MEDLINE | ID: mdl-17565251

12.

Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyper-acetylated histones, and modulated gene expression profile.

Yamada, Hisashi; Arakawa, Yasuhiro; Saito, Shinobu; Agawa, Miyuki; Kano, Yasuhiko; Horiguchi-Yamada, Junko.

Leuk Res ; 30(6): 723-34, 2006 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-16260035

13.

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.

Mori, Kiyoshi; Kamiyama, Yukari; Kondo, Tetsuro; Kano, Yasuhiko; Kodama, Tetsuro.

Cancer Chemother Pharmacol ; 58(1): 86-90, 2006 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16447041

14.

Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro.

Kano, Yasuhiko; Akutsu, Miyuki; Tsunoda, Saburo; Izumi, Tohru; Kobayashi, Hiroyuki; Inoue, Koichi; Mori, Kiyoshi; Fujii, Hirofumi; Mano, Hiroyuki; Odgerel, Tsogbadrakh; Furukawa, Yusuke.

Oncol Res ; 16(2): 85-95, 2006.

Artículo en Inglés | MEDLINE | ID: mdl-16898269

15.

Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c.

Nishimura, Noriko; Furukawa, Yusuke; Sutheesophon, Krittaya; Nakamura, Mitsuru; Kishi, Kenji; Okuda, Keiko; Sato, Yuko; Kano, Yasuhiko.

Oncogene ; 22(26): 4074-82, 2003 Jun 26.

Artículo en Inglés | MEDLINE | ID: mdl-12821941

16.

Relative importance of apoptosis and cell cycle blockage in the synergistic effect of combined R115777 and imatinib treatment in BCR/ABL-positive cell lines.

Miyoshi, Takuji; Nagai, Tadashi; Ohmine, Ken; Nakamura, Makiko; Kano, Yasuhiko; Muroi, Kazuo; Komatsu, Norio; Ozawa, Keiya.

Biochem Pharmacol ; 69(11): 1585-94, 2005 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-15896338

17.

Establishment and characterization of A novel Philadelphia-chromosome positive chronic myeloid leukemia cell line, TCC-S, expressing P210 and P190 BCR/ABL transcripts but missing normal ABL gene.

Van, Phan Nguyen Thanh; Xinh, Phan Thi; Kano, Yasuhiko; Tokunaga, Katsushi; Sato, Yuko.

Hum Cell ; 18(1): 25-33, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-16130897

18.

[Anti-parietal cell antibody].

Kano, Yasuhiko; Akutsu, Miyuki.

Nihon Rinsho ; 68 Suppl 6: 602-4, 2010 Jun.

Artículo en Japonés | MEDLINE | ID: mdl-20942141

19.

[Anti-intrinsic factor antibody].

Kano, Yasuhiko; Oda, Mitsuhiro.

Nihon Rinsho ; 68 Suppl 6: 605-7, 2010 Jun.

Artículo en Japonés | MEDLINE | ID: mdl-20942142

20.

Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.

Kawano, Takeshi; Horiguchi-Yamada, Junko; Saito, Shinobu; Iwase, Satsuki; Furukawa, Yusuke; Kano, Yasuhiko; Yamada, Hisashi.

Leuk Res ; 28(6): 623-9, 2004 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-15120940

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: